Cipla [CIPLA] vs NGL Fine-Chem [NGLFINE] Detailed Stock Comparison

Cipla Ltd.

NSE
Loading...

NGL Fine-Chem Ltd.

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Cipla Ltd. wins in 14 metrics, NGL Fine-Chem Ltd. wins in 6 metrics, with 0 ties. Cipla Ltd. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Cipla Ltd. NGL Fine-Chem Ltd. Better
P/E Ratio (TTM) 23.20 38.56 Cipla Ltd.
Price-to-Book Ratio 3.20 4.57 Cipla Ltd.
Debt-to-Equity Ratio 1.42 29.38 Cipla Ltd.
PEG Ratio -0.48 0.03 NGL Fine-Chem Ltd.
EV/EBITDA 14.99 27.25 Cipla Ltd.
Profit Margin (TTM) 16.26% 7.92% Cipla Ltd.
Operating Margin (TTM) 14.03% 13.44% Cipla Ltd.
EBITDA Margin (TTM) 14.03% 13.44% Cipla Ltd.
Return on Equity 16.85% 7.48% Cipla Ltd.
Return on Assets (TTM) 14.10% 4.87% Cipla Ltd.
Free Cash Flow (TTM) $34.57B $-949.49M Cipla Ltd.
Dividend Yield 1.72% 0.26% Cipla Ltd.
1-Year Return -7.69% 190.36% NGL Fine-Chem Ltd.
Price-to-Sales Ratio (TTM) 3.77 3.07 NGL Fine-Chem Ltd.
Enterprise Value $954.58B $14.44B Cipla Ltd.
EV/Revenue Ratio 3.41 3.23 NGL Fine-Chem Ltd.
Gross Profit Margin (TTM) 62.20% 53.33% Cipla Ltd.
Revenue per Share (TTM) $346 $723 NGL Fine-Chem Ltd.
Earnings per Share (Diluted) $56.28 $57.61 NGL Fine-Chem Ltd.
Beta (Stock Volatility) 0.06 0.56 Cipla Ltd.

Cipla Ltd. vs NGL Fine-Chem Ltd. Stock Performance Analysis

Loading Price Chart...

CIPLA
NGLFINE

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Cipla Ltd.-0.53%-0.42%-3.49%6.32%-8.35%-7.92%
NGL Fine-Chem Ltd.1.98%17.19%32.28%42.63%133.76%122.63%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Cipla Ltd.-7.69%38.10%44.59%185.62%323.08%558.95%
NGL Fine-Chem Ltd.190.36%86.41%63.13%63.13%63.13%63.13%

Performance & Financial Health Analysis: Cipla Ltd. vs NGL Fine-Chem Ltd.

MetricCIPLANGLFINE
Market Information
Market Cap i₹1.06T₹13.81B
Market Cap CategoryLarge capSmall cap
10 Day Avg. Volume i2,059,1616,556
90 Day Avg. Volume i1,842,4176,158
Last Close₹1,382.10₹3,109.30
52 Week Range₹1,165.70 - ₹1,673.00₹980.00 - ₹3,200.00
% from 52W High-17.39%-2.83%
All-Time High₹1,673.00 (Oct 23, 2025)₹3,200.00 (Jun 15, 2026)
% from All-Time High-17.39%-2.83%
Growth Metrics
Quarterly Revenue Growth0.02%0.43%
Quarterly Earnings Growth-0.57%11.29%
Financial Health
Profit Margin (TTM) i0.16%0.08%
Operating Margin (TTM) i0.14%0.13%
Return on Equity (TTM) i0.17%0.07%
Debt to Equity (MRQ) i1.4229.38
Cash & Liquidity
Book Value per Share (MRQ)₹407.53₹485.91
Cash per Share (MRQ)₹131.25₹90.47
Operating Cash Flow (TTM) i₹55.16B₹206.13M
Levered Free Cash Flow (TTM) i₹52.73B₹211.24M
Dividends
Last 12-Month Dividend Yield i1.72%0.26%
Last 12-Month Dividend i₹26.00₹3.50

Valuation & Enterprise Metrics Analysis: Cipla Ltd. vs NGL Fine-Chem Ltd.

MetricCIPLA (Apr 24, 2026)NGLFINE (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i23.2038.56
Forward P/E i23.62N/A
PEG Ratio i-0.480.03
Price to Sales (TTM) i3.773.07
Price to Book (MRQ) i3.204.57
Market Capitalization
Market Capitalization i₹1.06T₹13.81B
Enterprise Value i₹954.58B₹14.44B
Enterprise Value Metrics
Enterprise to Revenue i3.413.23
Enterprise to EBITDA i14.9927.25
Risk & Other Metrics
Beta i0.060.56
Book Value per Share (MRQ) i₹407.53₹485.91

Financial Statements Comparison: Cipla Ltd. vs NGL Fine-Chem Ltd.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricCIPLA (2025)NGLFINE (2025)
Revenue/Sales i271.45B3.63B
Cost of Goods Sold i97.63B1.82B
COGS % of Revenue i36.0%50.2%
Gross Profit i173.83B1.81B
Gross Margin i64.0%49.8%
Research & Development i3.76BN/A
Operating Income (EBIT) i61.44B224.26M
Operating Margin i22.6%6.2%
EBITDA i74.32B419.90M
EBITDA Margin i27.4%11.6%
Pre-Tax Income i68.21B277.14M
Pre-Tax Income % of Revenue i25.1%7.6%
Income Tax i15.30B65.90M
Income Tax % of Revenue i5.6%1.8%
Net Income (Profit) i52.69B211.24M
Profit Margin i19.4%5.8%

Balance Sheet & Liquidity Metrics

MetricCIPLA (2025)NGLFINE (2025)
Cash & Equivalents i5.89B5.83M
Total Current Assets i232.89B2.35B
Total Current Assets % of Revenue i85.8%64.8%
Total Current Liabilities i54.84B1.19B
Total Current Liabilities % of Revenue i20.2%32.8%
Long-Term Debt i2.52B253.36M
Long-Term Debt % of Revenue i0.9%7.0%
Total Shareholders Equity i312.89B2.82B
Retained Earnings i256.44B2.77B
Retained Earnings % of Revenue i94.5%76.3%
Property, Plant & Equipment i52.62B1.42B

Cash Flow Statement Comparison

MetricCIPLA (2025)NGLFINE (2025)
Operating Cash Flow i55.16B206.13M
Operating Cash Flow % of Revenue i20.3%5.7%
Capital Expenditures i-11.37B-737.60M
Free Cash Flow i34.57B-949.49M
FCF Margin i12.7%-26.2%
Debt Repayment i-980.10MN/A
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricCIPLANGLFINE
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i807.78M6.18M
Float Shares i563.37M1.58M
% Held by Insiders i30.96%72.74%
% Held by Institutions i40.34%0.00%
% Held by Public i28.70%27.26%

Dividend Analysis & Yield Comparison: Cipla Ltd. vs NGL Fine-Chem Ltd.

MetricCIPLANGLFINE
Last 12-Month Dividend i₹26.00₹3.50
Last 12-Month Dividend Yield i1.72%0.26%
3-Year Avg Annual Dividend i₹16.00₹2.33
3-Year Avg Dividend Yield i0.76%0.10%
3-Year Total Dividends i₹48.00₹7.00
Ex-Dividend DateJun 27, 2025Aug 12, 2025